NEW STUDY: BEAUTIFUL SKIN FOREVER STUDY SHOWS RARE COMBINATION OF OUTCOMES WITH LUTEMAX 2020

New study: Beautiful skin forever study shows rare combination of outcomes with Lutemax 2020

Morristown, N.J., December 15, 2016 – A new study—Beautiful Skin Forever—showed that supplementation with Lutemax 2020 resulted in a rare combination of outcomes that are attributed to beautiful, healthy skin. The findings were the subject of a paper, “Overall skin tone and skin-lightening-improving effects with oral supplementation of lutein and zeaxanthin isomers: a double-blind placebo-controlled clinical trial,” which was published in the journal Clinical, Cosmetic and Investigational Dermatology, 2016 (Juturu, et al.).

“We are seeing compelling science expanding the macular carotenoids beyond vision into exciting new categories such as skin health, and our robust clinical program is rapidly expanding this growing breadth of research,” said Lynda Doyle, Sr. VP, Global Marketing of OmniActive Health Technologies. “The results of the Beautiful Skin Forever Study serve as an important part of our Lutein For Every Age™ program, further supporting our ongoing efforts to help build new claims and concepts for the industry.”

Beautiful Skin Forever was a 12 week double-blind, placebo-controlled parallel study in healthy men and women (ages 18-45 years) with mild to moderate dry skin in which subjects supplemented daily with either a placebo or 10 mg Lutemax 2020. Lutemax 2020 supplementation resulted in improved overall skin tone, skin lightening/brightening, photo-protection and skin firmness.

Award-winning, globally-recognized Lutemax 2020 is a naturally-derived marigold extract providing all three macular carotenoids (lutein and enhanced levels of both zeaxanthin isomers—RR-and RS [meso]-zeaxanthin) at the same 5:1 ratio as found in nature. FDA-GRAS notified Lutemax 2020 is manufactured under a fully vertically integrated source.

 For more information on Lutemax 2020, OmniActive’s ingredients or science, please contact Lynda Doyle at l.doyle@omniactives.com.

About OmniActive Health Technologies, Inc.

OmniActive Health Technologies (www.omniactives.com) offers a range of quality ingredients, which are innovative and scientifically validated for dietary supplementation, nutritional fortification, functional food/beverage, coloring, flavor enhancement and personal care applications. The company addresses complex challenges for customers in the dietary supplement, food and beverage space using technology-driven, sustainable solutions with application support within a global regulatory framework. Whether looking for a new ingredient to add to a finished product, or an ingredient solution to enhance an existing ingredient, you will find unmatched innovation at OmniActive.

Core products include carotenoids, plant extracts and specialty functional ingredients. OmniActive leverages international R&D strengths to deploy an array of state-of-the-art manufacturing technologies in extraction, purification, isolation and delivery of nutritional actives. The company’s manufacturing operations are located at multiple sites in India and are cGMP and HACCP system compliant.

About the journal Clinical, Cosmetic and Investigational Dermatology

Clinical, Cosmetic and Investigational Dermatology is an international, peer-reviewed, open access journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions. Normal and pathological processes in skin development and aging, their modification and treatment, as well as basic research into histology of dermal and dermal structures that provide clinical insights and potential treatment options are key topics for the journal.

Lutemax 2020 is a trademark of OmniActive Health Technologies Ltd.

go back to PRESS RELEASES